Bioactivity | N6-(2-Phenylethyl)adenosine (N6-Phenethyladenosine), an adenosine derivative, is a potent adenosine receptors (AR) agonist with Ki values of 11.8 nM, 30.1 nM, 0.63 nM for rat A1AR, human A1AR and hA3AR, respectively[1]. | ||||||||||||
Target | Ki: 11.8 nM (rA1AR), 30.1 nM (hA1AR) and 0.63 nM (hA3AR) | ||||||||||||
Invitro | N6-(2-Phenylethyl)adenosine (N6-Phenethyladenosine) inhibits rA2AR (IC50=560 nM), hA2AR (IC50=2250 nM) in CHO cells[1]. | ||||||||||||
Name | N6-(2-Phenylethyl)adenosine | ||||||||||||
CAS | 20125-39-7 | ||||||||||||
Formula | C18H21N5O4 | ||||||||||||
Molar Mass | 371.39 | ||||||||||||
Appearance | Solid | ||||||||||||
Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
Storage |
|
||||||||||||
Reference | [1]. Tchilibon S, et al. Exploring distal regions of the A3 adenosine receptor binding site: sterically constrained N6-(2-phenylethyl)adenosine derivatives as potent ligands. Bioorg Med Chem. 2004 May 1;12(9):2021-34. |